| RA patients (n= 45) | Healthy controls (n= 45) |
---|---|---|
Age, mean ± SD (years) | 60 ± 10.1 | 55 ± 7.8 |
Female, n (%) | 32 (71) | 32 (71) |
Rheumatoid factor positive, n (%) | 40 (89) | N/A |
DAS28, mean ± SD | 3.1 ± 1.7 | N/A |
ESR, median (P25 to P75) | 14 (5 to 28.5) | N/A |
CRP, median (P25 to P75) | 0 (0 to 12) | N/A |
Smoking, n (%) | 16 (32) | -- |
BMI, mean ± SD | 25 ± (3.3) | -- |
Anti-rheumatic medication, n (%) | 15 (33) | N/A |
   Methotrexate | 22 (49) | N/A |
   Other DMARD | 11 (24) | N.A |
   Biological DMARD | 15 (33) | N/A |
Oral glucocorticoids, n (%) | 8 (18) | N/A |